Related Experiment Video
Updated: Aug 12, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Cardiovascular risk factors in HIV-infected patients
1HIV Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, 2010, Australia. acarr@stvincents.com.au
Insights
Highly active antiretroviral therapy (HAART) can cause dyslipidemia and insulin resistance, increasing cardiovascular disease (CVD) risk. Treatment strategies for these conditions are unclear, especially for patients with lower HIV progression risk.
Area of Science:
- Internal Medicine
- Cardiology
- Infectious Diseases
Background:
- Highly active antiretroviral therapy (HAART) is associated with persistent dyslipidemia and insulin resistance.
- These metabolic changes are suspected to increase the incidence of cardiovascular disease (CVD) in patients on HAART.
- Both protease inhibitors (PIs) and nucleoside analog reverse transcriptase inhibitors (NRTIs) contribute to these adverse effects.
Purpose of the Study:
- To review the relationship between HAART, dyslipidemia, insulin resistance, and cardiovascular disease (CVD).
- To evaluate the current treatment strategies for managing dyslipidemia and insulin resistance in patients on HAART.
- To clarify the safety, efficacy, and optimal roles of various treatment interventions.
Main Methods:
- Review of existing literature on HAART, metabolic complications, and CVD.
- Analysis of studies investigating the impact of PIs and NRTIs on lipid and glucose metabolism.
- Evaluation of treatment strategies including lifestyle changes, pharmacotherapy, and antiretroviral regimen modification.
Main Results:
- HAART-induced dyslipidemia and insulin resistance are linked to increased CVD risk.
- PIs have direct metabolic effects, while both PIs and NRTIs contribute indirectly via lipodystrophy.
- Previous studies on CVD incidence and HAART lacked prospective design and adequate power.
- The relative safety and efficacy of management strategies for dyslipidemia and insulin resistance remain unclear.
Conclusions:
- Management of dyslipidemia and insulin resistance is recommended for HAART patients, particularly those with multiple CVD risk factors.
- Treatment benefits are greatest in individuals with higher perceived CVD risk and lower risk of HIV disease progression.
- Further prospective studies are needed to establish definitive treatment guidelines and assess long-term outcomes.
Abstract:
Highly active antiretroviral therapy (HAART) commonly leads to persistent dyslipidemia and insulin resistance that appear likely to confer an increased incidence of cardiovascular disease (CVD). Both protease inhibitors (PIs) and, to a lesser extent, nucleoside analog reverse transcriptase inhibitors (NRTIs) appear to be involved, through direct metabolic effects of PIs and an indirect effect of PI and NRTI-related lipodystrophy. Several studies have found a variable relationship between CVD incidence and HAART, but these studies were not prospective and may not have been adequately powered. A variety of treatment strategies have been evaluated for dyslipidemia and insulin resistance, including lifestyle changes, drugs, and antiretroviral switching, but their relative safety, efficacy and roles are unclear. Although treatment of dyslipidemia and insulin resistance is commonly recommended, it should be remembered that such therapy is likely to be of greater benefit in those with a greater perceived CVD risk (i.e., multiple risk factors) and the lowest risk of HIV disease progression.
Related Concept Videos
Retrovirus Life Cycles
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cryptococcal Meningitis

